Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Marc E. Rothenberg, Evan S. Dellon, Margaret H. Collins, Ikuo Hirano, Mirna Chehade, Albert J. Bredenoord, Alfredo J. Lucendo, Jonathan M. Spergel, Xian Sun, Jennifer D. Hamilton, Eric Mortensen, Elizabeth Laws, Jennifer Maloney, Leda Mannent, Eilish McCann, Xia Liu, Lila Glotfelty, Arsalan Shabbir